This recent study examined extracapsular spread (ECS) incidence and prognostic significance in melanoma patients with stage III disease. It found ECS is a significant disease specific survival, progression-free survival, and overall survival indicator in sentinel lymph node positive and nodal disease.
This recent Australian study tested wearable UV sensors as a means of improving sun protection in young adults at an outdoor festival. It found that those provided with the sensor improved their use of sunglasses and sunscreen, with participants reporting it a useful tool to remind them to use sun protection.
This recent study analysed sunscreen application technique amongst patients with a history of skin cancer. It found skin cancer survivors of both genders effectively applied sunscreen in line with recommended quantity guidelines, but men were significantly better at protecting their ears.
This recent study puts forward a feasible stepped-care model to treat fear of cancer recurrence or progression in people with metastatic melanoma treated with immunotherapy or targeted therapy.
According to this recent study, rapid acceleration in tumour growth is rare in melanoma patients treated with immune checkpoint inhibitors.
This recent study evaluated the influence of histological subtype, tumor localization and Fitzpatrick phototype on the risk to develop basal cell carcinoma in highly UV-exposed cases and controls compared to those with moderate or low solar UV exposure. It found the risk to develop basal cell carcinoma in highly occupationally UV-exposed skin was doubled consistently, independent of histological subtype, tumor localization and Fitzpatrick phototype.
This recent study found that artificial intelligence can improve the overall accuracy and diagnostic performance of dermatologists in dichotomous image–based discrimination between melanoma and nevus, supporting the argument for AI-based tools to aid clinicians in skin lesion classification.
This recent study compared oncological outcomes of advanced melanoma patients treated with isolated limb infusion in America and Australia. It found Australian patients were treated at an earlier disease stage than American patients with better in-field progression free survival for stage 3B disease. American patients treated after the availability of new systemic therapies had a better overall survival.
According to this recent study, T cell-induced interferon-γ correlates the best to immune checkpoint blockade therapy.
The Melanoma Institute of Australia have recently released a suite of online calculators to predict a person’s risk of developing their first melanoma; their risk of developing a second or subsequent primary melanoma; and their risk of a primary melanoma having spread to nearby lymph nodes.